Cancel
Eric Matthews
Chief Commercial Officer
@
Arcus Biosciences
k2n55ygd8@51v7yzvp.4yv
Sign up to see email
See Linkedin
Known information
- Has more than 20 years of experience in biopharmaceuticals.
- Has launched 15 new medicines, including Avastin®, Tarceva®, Tecentriq®, and Imfinzi®.
- Previously worked at AstraZeneca and Roche/Genentech.
- Worked on first-in-class immunotherapy products and novel therapeutic combinations.
- Has experience as a Congressional Health Policy Analyst.
- Was involved in developing the Medicare Modernization Act.
About Arcus Biosciences
Arcus Biosciences develops differentiated molecules and combination therapies for cancer treatment, with a clinical pipeline that includes domvanalimab, etrumadenant, and zimberelimab. The company partners with Gilead Sciences and Taiho Pharmaceutical and conducts global clinical trials in various cancer types.
Report inaccurate information